158 related articles for article (PubMed ID: 26378157)
1. Activity of single-agent decitabine in atypical chronic myeloid leukemia.
Hausmann H; Bhatt VR; Yuan J; Maness LJ; Ganti AK
J Oncol Pharm Pract; 2016 Dec; 22(6):790-794. PubMed ID: 26378157
[TBL] [Abstract][Full Text] [Related]
2. Studies of decitabine with allogeneic progenitor cell transplantation.
Giralt S; Davis M; O'Brien S; van Besien K; Champlin R; de Vos D; Kantarjian H
Leukemia; 1997 Mar; 11 Suppl 1():S32-4. PubMed ID: 9130690
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and side-effects of decitabine in treatment of atypical chronic myeloid leukemia.
Tong X; Li J; Zhou Z; Zheng D; Liu J; Su C
Leuk Lymphoma; 2015 Jun; 56(6):1911-3. PubMed ID: 25426665
[No Abstract] [Full Text] [Related]
4. Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study.
Ravandi F; Kantarjian H; Cohen A; Davis M; O'Brien S; Anderlini P; Andersson B; Claxton D; Donato M; Gajewski J; Khouri I; Korbling M; Ueno N; deVos D; Champlin R; Giralt S
Bone Marrow Transplant; 2001 Jun; 27(12):1221-5. PubMed ID: 11548839
[TBL] [Abstract][Full Text] [Related]
5. Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome.
Pusic I; Choi J; Fiala MA; Gao F; Holt M; Cashen AF; Vij R; Abboud CN; Stockerl-Goldstein KE; Jacoby MA; Uy GL; Westervelt P; DiPersio JF
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1761-9. PubMed ID: 26055299
[TBL] [Abstract][Full Text] [Related]
6. Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses.
Cruijsen M; Hobo W; van der Velden WJFM; Bremmers MEJ; Woestenenk R; Bär B; Falkenburg JHF; Kester M; Schaap NPM; Jansen J; Blijlevens NNM; Dolstra H; Huls G
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1000-1008. PubMed ID: 26860635
[TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Schroeder T; Rautenberg C; Krüger W; Platzbecker U; Bug G; Steinmann J; Klein S; Hopfer O; Nachtkamp K; Kondakci M; Geyh S; Haas R; Germing U; Bornhäuser M; Kobbe G
Ann Hematol; 2018 Feb; 97(2):335-342. PubMed ID: 29151133
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.
de Lima M; Ravandi F; Shahjahan M; Andersson B; Couriel D; Donato M; Khouri I; Gajewski J; van Besien K; Champlin R; Giralt S; Kantarjian H
Cancer; 2003 Mar; 97(5):1242-7. PubMed ID: 12599231
[TBL] [Abstract][Full Text] [Related]
9. [Effect of decitabine on immune regulation in patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Wang J; Zhou J; Zheng HF; Fu ZZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1448-52. PubMed ID: 25338605
[TBL] [Abstract][Full Text] [Related]
10. Decitabine for relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Cui JK; Xiao Y; You Y; Shi W; Li Q; Luo Y; Jiang L; Zhong ZD
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):693-698. PubMed ID: 29058281
[TBL] [Abstract][Full Text] [Related]
11. Decitabine treatment for acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation.
Liu XL; Zhao X; Wang C; Gao SJ; Tan YH
J Biol Regul Homeost Agents; 2017; 31(1):171-175. PubMed ID: 28337888
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
[TBL] [Abstract][Full Text] [Related]
13. Acute graft-versus-host disease in a nonhematopoietic stem cell transplantation candidate treated with decitabine followed by granulocyte colony-stimulating factor-primed peripheral blood stem cells infusion: a special entity of the disease?
Yuan L; Sun L; Yang L; Jing Y
Transfusion; 2014 Jan; 54(1):190-3. PubMed ID: 23621702
[TBL] [Abstract][Full Text] [Related]
14. Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia.
Craddock C; Labopin M; Robin M; Finke J; Chevallier P; Yakoub-Agha I; Bourhis JH; Sengelov H; Blaise D; Luft T; Hallek M; Kröger N; Nagler A; Mohty M
Haematologica; 2016 Jul; 101(7):879-83. PubMed ID: 27081178
[TBL] [Abstract][Full Text] [Related]
15. Decitabine prior to salvaged unrelated cord blood transplantation for refractory or relapsed childhood acute leukemia.
Zhou H; Zheng C; Zhu X; Tang B; Tong J; Zhang X; Zhang L; Liu H; Sun Z
Pediatr Transplant; 2016 Dec; 20(8):1117-1124. PubMed ID: 27620713
[TBL] [Abstract][Full Text] [Related]
16. Decitabine as a conditioning regimen in haploidentical stem cell transplantation for refractory acute myeloid leukaemia.
Zhang C; Chen XH; Liu J; Gao L; Liu Y; Gao L; Kong PY; Zhang X
J Clin Pharm Ther; 2015 Jun; 40(3):336-8. PubMed ID: 25825260
[TBL] [Abstract][Full Text] [Related]
17. Effect of Decitabine Combined with Unrelated Cord Blood Transplantation in an Adult Patient with -7/EVI1+ Acute Myeloid Leukemia: a Case Report and Literature Review.
Jiang YZ; Su GP; Dai Y; He HS; Huang LQ; Sun ZM; Huang DP
Ann Clin Lab Sci; 2015; 45(5):598-601. PubMed ID: 26586716
[TBL] [Abstract][Full Text] [Related]
18. [The safety of decitabine as bridging pretreatment regimen before hematopoietic stem cell transplantation in pediatric hematological malignancies].
Fan LY; Hu SY; Xiao PF; Lu J; Li J; Yao YH; Ling J; Kong LJ; Liu H; Bian XN
Zhonghua Nei Ke Za Zhi; 2018 Sep; 57(9):679-682. PubMed ID: 30180454
[TBL] [Abstract][Full Text] [Related]
19. Decitabine in chronic leukemias.
Issa JP; Byrd JC
Semin Hematol; 2005 Jul; 42(3 Suppl 2):S43-9. PubMed ID: 16015505
[TBL] [Abstract][Full Text] [Related]
20. Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG).
Becker H; Suciu S; Rüter BH; Platzbecker U; Giagounidis A; Selleslag D; Labar B; Germing U; Salih HR; Muus P; Pflüger KH; Hagemeijer A; Schaefer HE; Fiaccadori V; Baron F; Ganser A; Aul C; de Witte T; Wijermans PW; Lübbert M
Ann Hematol; 2015 Dec; 94(12):2003-13. PubMed ID: 26400023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
